Insider activity at KalVista Pharmaceuticals, Inc. has been all selling for a year now: about $7.1 million from six sellers, and zero buyers with their own money.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Yea Christopher | Executive Officer | Sell | 33,800 | $26.78 | $905K | SEC |
| May 27, 2026 | Yea Christopher | Executive Officer | Sell | 1,966 | $26.78 | $53K | SEC |
| May 27, 2026 | Sweeny Nicole | Executive Officer | Sell | 1,489 | $26.78 | $40K | SEC |
| May 27, 2026 | Audhya Paul K. | Executive Officer | Sell | 2,239 | $26.78 | $60K | SEC |
| May 26, 2026 | Palleiko Benjamin L | CEO | Sell | 10,926 | $26.78 | $293K | SEC |
| May 26, 2026 | Sweeny Nicole | Executive Officer | Sell | 1,861 | $26.78 | $50K | SEC |
| May 26, 2026 | Yea Christopher | Executive Officer | Sell | 2,358 | $26.78 | $63K | SEC |
| May 26, 2026 | Audhya Paul K. | Executive Officer | Sell | 2,685 | $26.78 | $72K | SEC |
| May 26, 2026 | Piekos Brian | CFO | Sell | 1,489 | $26.78 | $40K | SEC |
| May 19, 2026 | Yea Christopher | Executive Officer | Sell | 1,108 | $26.76 | $30K | SEC |
| May 19, 2026 | Audhya Paul K. | Executive Officer | Sell | 1,032 | $26.76 | $28K | SEC |
| May 19, 2026 | Palleiko Benjamin L | CEO | Sell | 1,129 | $26.76 | $30K | SEC |
| May 13, 2026 | Palleiko Benjamin L | CEO | Sell | 3,322 | $26.71 | $89K | SEC |
| Apr 20, 2026 | Sweeny Nicole | Executive Officer | Sell | 1,862 | $20.22 | $38K | SEC |
| Apr 20, 2026 | Piekos Brian | CFO | Sell | 1,862 | $20.22 | $38K | SEC |
In the last 12 months KalVista Pharmaceuticals, Inc. insiders made open-market purchases worth about $0 and sales worth about $7.1 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in KALV was filed on 2026-05-29.
No congressional trades in KALV were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).